Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06117397 · ClinicalTrials.gov registry record · NA
A Text Messaging Intervention to Reduce Perinatal Depression Risk
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06117397 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 40 participants.
The verdict
NCT06117397, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will screen pregnant individuals, send tailored text messages with links to enhanced content, and will include a peer chat function.This accessible text platform will leverage both the ease of use inherent in text messages and the power of enhanced content drawn evidence from based behavioral interventions (Interpersonal Therapy).
Interventions
- OTHER Text Messaging Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06117397
The ClinicalTrials.gov registry entry for NCT06117397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text Messaging Intervention is the first listed.
NCT06117397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06117397 about?
NCT06117397 is a clinical study titled "A Text Messaging Intervention to Reduce Perinatal Depression Risk". Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will screen pregnant individuals, send tailored text messages with links to enhanced content, and will i...
What is the current status of trial NCT06117397?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-09-05. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT06117397?
The interventions under investigation include: Text Messaging Intervention (OTHER).
Who is sponsoring clinical trial NCT06117397?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.